HARARE – The pharmaceutical industry in Zimbabwe is set to grow as two global pharmaceutical giants, Dubai-based Intrapharma and Egypt-based Pharco, plan to establish a manufacturing facility in Zimbabwe.
The new venture is expected to see the two companies establish a manufacturing facility in Victoria Falls under the Zimpharma name according to information provided.
This comes after Vice President Constantino Chiwenga met with representatives of the two companies in Egypt on the sidelines of the Africa Health Excon to finalize the deal.
“The pharmaceutical industry in Zimbabwe had collapsed and we are in the process of reshaping it. Industries were dead, but now we have revived over 15.
“The Dubai team and the Egypt team are now coming in with some of the technology that we don’t have and some other materials that we don’t have in Zimbabwe. From these new technologies, they will create 90 different types of drugs.
“When they came to Zimbabwe, they actually went round to see where they will set up their company and they chose Victoria Falls. Their coming in will also attract quiet a number of industries. A tripartite will be signed between Pharco, Intrapharma and Zimbabwe which will be called Zimpharma,” said Chiwenga.
The chairperson of Intrapharma, the Engineer Ibrahim Ramel, is convinced that the partnership will yield positive results.
“Zimbabwe is the best place for any investor looking to grow and develop because of the high quality of its workforce. This strategic project is a win-win situation. We find great support from the leaders. We hope you will see our product in Zimbabwe by the end of this year,” he said.
Zimbabwe last month reportedly brokered a deal with Indonesian pharmaceutical giant Biopharma to set up its factory at NatPharm in Harare, while Zimpharma’s factory is under construction in Victoria Falls.
